V.L. Kronzer, MD MSCI, J.M. Davis III, MD, MS, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota;
W. Huang, MSPH, A. Zaccardelli, BS, J.A. Sparks, MD, MMSc, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
J Rheumatol. 2022 Apr;49(4):358-364. doi: 10.3899/jrheum.210580. Epub 2021 Oct 15.
We aimed to determine whether specific respiratory tract diseases are associated with increased rheumatoid arthritis (RA) risk.
This case-control study within the Mass General Brigham Biobank matched newly diagnosed RA cases to 3 controls on age, sex, and electronic health record history. We identified RA using a validated algorithm and confirmed by medical record review. Respiratory tract disease exposure required 1 inpatient or 2 outpatient codes at least 2 years before the index date of RA clinical diagnosis or matched date. Logistic regression models calculated ORs for RA with 95% CIs, adjusting for confounders. We then stratified by serostatus ("seropositive" was positive rheumatoid factor and/or anticitrullinated protein antibodies) and smoking.
We identified 741 RA cases and 2223 controls (both median age 55, 76% female). Acute sinusitis (OR 1.61, 95% CI 1.05-2.45), chronic sinusitis (OR 2.16, 95% CI 1.39-3.35), and asthma (OR 1.39, 95% CI 1.03-1.87) were associated with increased risk of RA. Acute respiratory tract disease burden during the preindex exposure period was also associated with increased RA risk (OR 1.30 per 10 codes, 95% CI 1.08-1.55). Acute pharyngitis was associated with seronegative (OR 1.68, 95% CI 1.02-2.74) but not seropositive RA; chronic rhinitis/pharyngitis was associated with seropositive (OR 2.46, 95% CI 1.01-5.99) but not seronegative RA. Respiratory tract diseases tended towards higher associations in smokers, especially > 10 pack-years (OR 1.52, 95% CI 1.02-2.27, = 0.10 for interaction).
Acute and chronic sinusitis, pharyngitis, and acute respiratory burden increased RA risk. The mucosal paradigm of RA pathogenesis may involve the upper respiratory tract.
本研究旨在确定特定的呼吸道疾病是否与类风湿关节炎(RA)风险增加相关。
本病例对照研究在麻省总医院布列根生物库内进行,将新诊断的 RA 病例与年龄、性别和电子病历史相匹配的 3 名对照进行匹配。我们使用经过验证的算法确定 RA 病例,并通过病历审查进行确认。呼吸道疾病的暴露需要在 RA 临床诊断或匹配日期前至少 2 年有 1 次住院或 2 次门诊记录。逻辑回归模型计算了调整混杂因素后 RA 的比值比(OR)及其 95%置信区间(CI)。然后,我们按血清学状态(“血清阳性”是指阳性类风湿因子和/或抗瓜氨酸蛋白抗体)和吸烟情况进行分层。
我们共确定了 741 例 RA 病例和 2223 例对照(中位年龄均为 55 岁,76%为女性)。急性鼻窦炎(OR 1.61,95%CI 1.05-2.45)、慢性鼻窦炎(OR 2.16,95%CI 1.39-3.35)和哮喘(OR 1.39,95%CI 1.03-1.87)与 RA 风险增加相关。索引前暴露期内急性呼吸道疾病负担也与 RA 风险增加相关(每增加 10 个记录编码,OR 1.30,95%CI 1.08-1.55)。急性咽炎与血清阴性 RA 相关(OR 1.68,95%CI 1.02-2.74),但与血清阳性 RA 无关;慢性鼻炎/咽炎与血清阳性 RA 相关(OR 2.46,95%CI 1.01-5.99),但与血清阴性 RA 无关。呼吸道疾病在吸烟者中更易出现关联,尤其是吸烟超过 10 包年(OR 1.52,95%CI 1.02-2.27, = 0.10 用于交互作用检验)。
急性和慢性鼻窦炎、咽炎和急性呼吸道负担增加了 RA 风险。RA 发病机制的黏膜范式可能涉及上呼吸道。